[Immunological aspects of lymphogranulomatosis].
D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis; D001402:B-Lymphocytes / Q000276:immunology; D002213:Capsid / Q000276:immunology; D002455:Cell Division / Q000187:drug effects; D004854:Herpesvirus 4, Human / Q000276:immunology; D006689:Hodgkin Disease / Q000209:etiology / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular / Q000528:radiation effects; D007153:Immunologic Deficiency Syndromes / Q000276:immunology; D007694:Killer Cells, Natural / Q000276:immunology; D008213:Lymphocyte Activation / Q000187:drug effects; D008221:Lymphoid Tissue / Q000276:immunology; D008264:Macrophages / Q000276:immunology; D008934:Mitogens / Q000494:pharmacology; D009368:Neoplasm Transplantation; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology
D000914:Antibodies, Viral; D008934:Mitogens
Immunologicheskie aspekty limfogranulematoza.